October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...
In average-risk individuals, ColoSense demonstrated 93% sensitivity for detecting colorectal cancer (CRC) and 45% sensitivity for detecting advanced adenomas (AA). The CRC-PREVENT study evaluated more ...
False-positive multi-target stool tests are linked to higher rates of noncolorectal aerodigestive cancers, suggesting further ...
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease ST. LOUIS & HERCULES, ...
Automatically mailing a stool test kit to people's homes might be the best way to boost colon cancer screening among younger adults, a new study says. More 45- to 49-year-olds went ahead with cancer ...
At-home cancer tests are a great way to learn key information about your health without having to visit the doctor in person. This option is good for patients who don’t have time to go to the doctor’s ...
Colorectal cancer (CRC) is now the leading cause of cancer death in adults under 50 and the second leading cause of cancer death in the U.S., highlighting the importance of routine screenings. Adults ...
Rates of rectal cancer deaths are rising in adults under 50.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results